Clinical Trial Update: NRTI-Sparing Pilot Study [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating NRTI-sparing regimens in people with HIV; the study focusing on mitochondrial toxicity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: University of British Columbia | Conditions: HIV, Mitochondrial Toxicity | Phase 4 | Status: COMPLETED